Allied Health & Imaging · Independent exam preparation

Scientist in Cytogenetics — CG(ASCP) Preparation Guide Study Guide

Practise culture troubleshooting, FISH interpretation, chromosome analysis and laboratory quality decisions with 60 focused concepts and 20 explained questions.

By CertMedbry · Updated 1 November 2026

60 concepts explainedWorked examples & common pitfallsOfficial blueprint references

Learn to choose suitable specimens, troubleshoot chromosome preparations, interpret FISH and microarray findings, and distinguish constitutional abnormalities from acquired clones. This guide follows the CG(ASCP) pathway and emphasizes the chromosome analysis decisions that carry the greatest blueprint weight. Its 60 concepts are selective study targets; the complete ASCP BOC examination outline defines the full scope, and the outline's examples are nonexhaustive.

Try 20 free practice questions

What is the exam format?

Check the question types, timing and outline before planning your revision.

Which credential and pathway does this guide cover?

This guide is labeled for Scientist in Cytogenetics, CG(ASCP), awarded by the American Society for Clinical Pathology Board of Certification. The current examination guideline also covers CG(ASCPi), the international credential pathway. Sharing a content guideline does not establish identical eligibility requirements; candidates should use the requirements for their selected credential.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

How many questions are there, and how much time is allowed?

The official guideline specifies 100 questions in 2 hours 30 minutes. It does not identify a separate scored-question count or pretest-question count, so no such breakdown is asserted here.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

How is the examination delivered, and what question styles are specified?

The examination is computer administered using computer adaptive testing. All questions are multiple choice with one best answer. Questions may test theoretical application, calculations and disease correlations, or procedural techniques and quality assurance. The guideline does not establish remote delivery arrangements. This guide's fixed MCQ drills provide independent practice and do not reproduce adaptive delivery or predict passing.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

Which blueprint revision applies, and what are the domain weights?

The current guideline is revised December 5, 2025, with no separate effective date printed. Its weights are Specimen Preparation, Culture, and Harvest, 20–25%; Molecular Cytogenetic Testing, 15–25%; Chromosome Analysis and Imaging, 45–50%; and Laboratory Operations, 10–15%. This guide allocates its 60 concepts as 14, 12, 27 and 7 respectively. Questions and flashcards each allocate 4, 4, 9 and 3.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

Which jurisdiction governs regulatory questions?

The guideline explicitly bases regulatory questions on U.S. sources, including examples such as CLIA and FDA requirements. This applies to the shared CG examination guideline, including its CG(ASCPi) label. Local employment or laboratory licensing requirements are separate matters.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

How should the scientific reference dates be understood?

Scientific references retain their own publication or revision dates. The ACMG Section E compilation identifies a March 2020 base revision and includes separately dated consensus material. Its website directory date does not establish a new scientific revision. The examination guideline establishes tested scope; laboratory standards, assay instructions and scientific references support technical interpretation.

ACMG Technical Standards for Clinical Genetics Laboratories: Section E, Clinical Cytogenetics

ASCP BOC currently names this credential Scientist in Cytogenetics, CG(ASCP). The earlier Technologist in Cytogenetics label refers to this credential's naming history. These independently authored educational materials are not official ASCP examination questions.

Outline used: Current official CG examination guideline, revised December 5, 2025; no separate effective date is printed. The assigned Technologist in Cytogenetics label maps to the current Scientist in Cytogenetics credential. The canonical slug is preserved.

60 key concepts: understand, apply and avoid the traps

Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.

Specimen Preparation, Culture, and Harvest20–25%

1.How do specimen identity and the requested test determine acceptance?

A technically adequate specimen cannot yield a trustworthy patient result unless its identity and requested examination are established. Compare specimen identifiers with the order and maintain that association through aliquoting, culture, harvesting and reporting. Resolve discrepancies before processing can obscure their origin. The requested test also determines whether the submitted material is suitable: chromosome culture, interphase FISH and DNA analysis can require different preparation pathways even when requested for the same patient.

Apply it

Two blood tubes arrive with matching surnames but different medical record numbers on their orders. Hold the affected accession, preserve specimen integrity and resolve identification through the laboratory's documented discrepancy process before establishing cultures.

Common pitfall: Choosing the apparently more complete label substitutes an assumption for verified identity. Successful culture cannot repair uncertainty about whose cells were examined.

CMS State Operations Manual: Appendix C, Subpart K

2.How do specimen, target population and culture system determine the preparation pathway?

Conventional chromosome analysis generally requires viable cells capable of entering division, whereas DNA testing requires nucleic acid of adequate quantity and quality. Culture selection must also recover the intended population. Constitutional peripheral blood analysis commonly uses a suspension culture of heparinized blood with phytohaemagglutinin to stimulate responsive lymphocytes, predominantly T cells. Myeloid-neoplasm analysis generally uses marrow aspirate in short-term, unstimulated suspension cultures to recover dividing hematopoietic cells; routine lymphocyte stimulation could favor normal T cells instead. Tissue fibroblasts are recovered from fresh, aseptically collected tissue through explant outgrowth or tissue disaggregation and grown as an adherent monolayer without routine PHA stimulation. Clotting, transport delay, contamination and loss of viability can compromise blood or marrow cultures; formalin fixation prevents viable tissue culture. Container, anticoagulant, medium, transport temperature, culture duration and any disease-specific stimulation must match the specimen and assay rather than become universal requirements.

Apply it

Compare three requests. For a constitutional blood karyotype, collect blood in a culture-compatible heparin container and establish a PHA-stimulated suspension to examine responsive lymphocytes. For a suspected myeloid neoplasm, prioritize a representative marrow aspirate collected with a culture-compatible anticoagulant and promptly establish short-term unstimulated suspensions; a blood lymphocyte culture could miss the target clone. For a skin fibroblast study, submit fresh tissue in a sterile container with suitable transport medium and establish adherent outgrowth; tissue placed entirely in formalin cannot supply viable fibroblasts. If tissue also needs a validated FFPE FISH assay, allocate separate material before fixation. These choices share identity and viability requirements but do not share one stimulation schedule or culture system.

Common pitfall: Detectable DNA does not demonstrate cell viability, and abundant growth does not demonstrate recovery of the intended population. Disease-specific marrow stimulation, exact transport limits and assay-compatible anticoagulants require their own validated conditions; a constitutional blood protocol should not be transferred unchanged to marrow or tissue.

Preparation of Peripheral Blood Cells for Chromosome Analysis · European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms · European guidelines for constitutional cytogenomic analysis · Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

3.How does specimen quality influence culture yield?

Culture success depends on viable target cells, sufficient cellularity and conditions that support their growth. Delayed transport, inappropriate storage, clotting or microbial contamination can reduce the number of informative metaphases. Evaluate quality at receipt and document limitations before interpreting a poor yield. In neoplastic specimens, abundant cells do not necessarily mean abundant dividing malignant cells; the sampled population and its proliferative behavior determine what conventional analysis can reveal.

Apply it

A delayed marrow specimen produces few metaphases despite adequate total cellularity. Review transport history, viability and culture conditions, and consider complementary testing of the target population before interpreting the limited normal metaphases as exclusionary.

Common pitfall: A normal result from a poorly represented target population can be falsely reassuring. Total cell count alone does not establish useful cytogenetic sampling.

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms

4.Why must maternal tissue be separated from chorionic villi?

Maternal decidua can accompany chorionic villi and contribute cells or DNA to a prenatal specimen. If maternal cells grow preferentially or dominate an extract, the result may describe the mother rather than the pregnancy. Careful microscopic identification and dissection of villous tissue reduces this risk. A reassuring female result does not itself prove fetal origin; contamination assessment must address the specimen and analytical method actually used.

Apply it

A chorionic villus specimen contains recognizable villi mixed with decidua. Separate the villi before culture or extraction and retain appropriate material for contamination assessment when indicated, especially if subsequent findings could plausibly reflect maternal cells.

Common pitfall: A 46,XX result is not evidence that contamination is absent. Maternal cells may have a normal female complement and can overgrow fetal cells.

ACMG Technical Standards for Clinical Genetics Laboratories: Section E, Clinical Cytogenetics

5.Why are independently established cultures informative?

Independent cultures provide separate opportunities to recover the specimen's cell populations and evaluate reproducibility. An abnormality confined to one culture or colony may represent a culture-associated event, whereas recurrence across independent cultures strengthens evidence that it existed in the specimen. Independence begins at culture establishment; splitting one expanded culture later does not create independent biological evidence. Culture number and interpretation depend on specimen type, indication and the validated analytical approach.

Apply it

An unusual chromosome appears repeatedly in one prenatal culture but is absent from another independently established culture. Review colony relationships and specimen-specific mosaicism criteria before deciding whether the observation supports true mosaicism or a culture-associated finding.

Common pitfall: Several cells descended from one abnormal progenitor do not provide the same evidence as the abnormality recurring in independently established cultures or independent colonies.

ACMG Technical Standards for Clinical Genetics Laboratories: Section E, Clinical Cytogenetics

6.Which cells does phytohaemagglutinin stimulate for blood chromosome analysis?

Phytohaemagglutinin promotes mitogenic activation of responsive lymphocytes, predominantly T lymphocytes, allowing otherwise resting peripheral blood cells to enter division. It supplies a biological stimulus, not a chromosome stain or a mitotic arrest mechanism. Selecting a mitogen therefore selects which population is encouraged to proliferate. A routine stimulated blood culture may be appropriate for constitutional analysis but may poorly represent a neoplastic population that requires different culture conditions.

Apply it

A constitutional blood culture has very few metaphases after an omitted supplement is discovered. If the omitted reagent was phytohaemagglutinin, investigate failure of lymphocyte stimulation rather than first changing the chromosome banding procedure.

Common pitfall: Using a familiar mitogen for every specimen can favor the wrong cells. Successful stimulation of normal lymphocytes does not guarantee recovery of a malignant clone.

Phytohaemagglutinin, Reagent Grade: Instructions for Use

7.How does aseptic handling prevent misleading culture results?

Aseptic technique limits introduction of microorganisms and transfer of cells between specimens. Microbial contamination can alter medium conditions, damage cells and cause culture failure; cross-contamination can produce technically convincing chromosomes from the wrong source. Separate specimen handling, appropriately controlled work areas and clean reagent practices protect different parts of this risk. Investigate unexpected growth or discordant results through documented handling records rather than assuming every discrepancy has a biological explanation.

Apply it

Two cultures handled consecutively develop unexpected, unusually similar findings. Review specimen separation, shared reagents and processing records while evaluating biological explanations. Preserve the original materials so an independent preparation can help distinguish contamination from a real result.

Common pitfall: Clear medium does not exclude transfer of another patient's cells. Antimicrobial additives also do not replace aseptic technique or prevent specimen mix-ups during processing.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

8.When is a culture ready for harvest?

Harvest timing should reflect cell growth, mitotic activity and the culture system, rather than elapsed time alone. Monolayers require assessment of attachment, density and morphology; suspension cultures require evaluation of viable growth and expected division. Excessive confluence can reduce useful proliferation, while harvesting a sparse culture can produce inadequate yield. Document observations so low mitotic index can be traced to biological growth, culture maintenance or the subsequent harvest process.

Apply it

Two fibroblast flasks reach the planned harvest day, but one remains sparse and the other is densely confluent. Assess each flask's growth and morphology individually before applying the same harvest decision to both cultures.

Common pitfall: A fixed calendar time is a scheduling aid, not proof of readiness. More cells can coexist with fewer useful metaphases when growth conditions deteriorate.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

9.How does colcemid exposure affect metaphase recovery and morphology?

Colcemid disrupts microtubule function and prevents normal mitotic spindle activity, accumulating dividing cells in metaphase. Exposure must balance metaphase recovery against chromosome morphology: prolonged arrest can produce more contracted chromosomes with less useful band detail. It cannot stimulate resting cells to proliferate. Interpret poor yield alongside cell growth and reagent condition, and use validated concentration and exposure conditions for the specimen rather than assuming that more inhibitor improves every preparation.

Apply it

A preparation contains many metaphases, but chromosomes are consistently short and highly contracted. Review mitotic inhibitor exposure as a possible contributor before increasing arrest time merely to obtain an even higher metaphase count.

Common pitfall: Mitotic arrest and mitogenic stimulation act at different stages. Increasing colcemid cannot rescue a culture whose cells never entered the cell cycle.

KaryoMAX Colcemid Solution: Instructions for Use, revision B.0

10.Why does hypotonic treatment improve chromosome spreading?

A hypotonic solution creates an osmotic gradient that moves water into cells, increasing cell volume and helping chromosomes separate during subsequent preparation. Insufficient swelling can leave crowded metaphases; excessive treatment can damage cells and increase chromosome loss or scattered material. The useful endpoint depends on specimen and conditions, so timing, temperature and solution preparation must be controlled. Hypotonic treatment changes cellular spacing rather than creating chromosome bands or arresting mitosis.

Apply it

Metaphases remain tightly clustered despite adequate mitotic activity. Review hypotonic solution preparation, temperature and exposure alongside slide conditions. Adjust one validated parameter at a time so improved spreading can be linked to a specific change.

Common pitfall: Longer hypotonic treatment is not automatically better. Over-swelling may create incomplete spreads that resemble numerical abnormalities or reduce the number of interpretable cells.

Phytohaemagglutinin, Reagent Grade: Instructions for Use

11.How does methanol–acetic acid fixation support chromosome preparation?

Methanol–acetic acid fixation preserves chromosome material while removing water and reducing cytoplasmic interference. Repeated controlled fixative changes help produce clean preparations suitable for spreading and banding. Fixative composition, freshness and mixing influence morphology, but fixation cannot restore viability or reverse upstream culture failure. Distinguish a dirty, cytoplasm-rich preparation from a low-mitotic-index preparation because their most informative troubleshooting steps occur at different stages of the workflow.

Apply it

A harvest has adequate metaphases but persistent cytoplasmic background. Review fixative preparation and changes, pellet resuspension and handling before altering lymphocyte stimulation, because the observed defect arises after cells have already reached mitosis.

Common pitfall: Fixation is not interchangeable with tissue preservation for viable-cell culture. Once cells are fixed, they cannot be returned to culture to increase metaphase yield.

Preparation of Peripheral Blood Cells for Chromosome Analysis

12.Which slide conditions control metaphase spreading?

Metaphase spreading reflects the interaction of cell suspension concentration, slide cleanliness, humidity, temperature and evaporation. Cells must open sufficiently to separate chromosomes without scattering them beyond recognition. Dense suspensions produce overlapping cells; inappropriate drying can leave compact or disrupted spreads. Evaluate whole-slide patterns and representative metaphases before changing conditions. A spreading defect is a preparation problem and should not be interpreted immediately as a biological chromosome loss or structural change.

Apply it

After a seasonal humidity change, several specimens develop compact spreads despite previously reliable harvests. Review room conditions and slide drying behavior across the batch before changing each specimen's culture or assuming a shared biological abnormality.

Common pitfall: One well-spread cell cannot establish overall slide quality. Conversely, scattered chromosomes from a disrupted cell should not be counted as a reliable hypodiploid metaphase.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

13.How does trypsin–Giemsa banding reveal chromosome identity?

Controlled proteolytic treatment followed by Giemsa staining produces reproducible G-band patterns that support chromosome identification and structural comparison. Under-treatment can leave poorly differentiated, uniformly dark chromosomes; excessive treatment can degrade morphology and weaken useful band detail. Interpret banding quality separately from chromosome length because long chromosomes can still be poorly banded. Optimize digestion and staining using appropriate preparation controls instead of assuming that greater stain intensity means better analytical resolution.

Apply it

A slide shows dark chromosomes with little internal contrast, while an acceptable control slide bands normally. Review the specimen slide's digestion and preparation characteristics before increasing image contrast or treating the pattern as an unusual chromosome variant.

Common pitfall: Digital contrast cannot reconstruct bands that preparation failed to reveal. Excessive digestion may make chromosomes look pale while also destroying the structural detail needed for interpretation.

Preparation of Peripheral Blood Cells for Chromosome Analysis

14.How should culture failure be localized within the workflow?

Troubleshooting begins by identifying the failed outcome: absent growth, low mitotic activity, poor chromosome spreading or inadequate banding. These observations implicate different stages. Compare specimen quality, culture records, reagent lots, equipment conditions and contemporaneous controls to distinguish isolated biological limitations from a shared process failure. Document both the investigation and its consequences for the result. A technically limited examination requires a limitation that matches what was actually recovered and assessed.

Apply it

Three unrelated cultures fail after introduction of a new medium lot, while cultures established earlier grow normally. Investigate the shared lot and preparation records, preserve evidence and assess other affected cases before attributing each failure to specimen quality.

Common pitfall: Repeating the entire process without identifying a plausible cause can reproduce the same failure. A successful repeat alone does not explain the original defect.

42 CFR Part 493: Laboratory Requirements, October 1, 2025 edition

Molecular Cytogenetic Testing15–25%

15.When does interphase FISH provide information that metaphase FISH cannot?

Interphase FISH evaluates targeted sequences in nondividing nuclei, allowing assessment when metaphases are scarce and enabling larger targeted cell counts. Metaphase FISH places signals on visible chromosomes, helping establish chromosomal location and structural relationships. Neither approach surveys every possible abnormality merely because fluorescence is present. Choose between them according to whether the question concerns targeted signal frequency, chromosome localization or a structural arrangement requiring direct visualization of the chromosome.

Apply it

A marrow has few metaphases, but the clinical question concerns a specific rearrangement detectable by a validated interphase assay. Use targeted interphase analysis while recognizing that it will not provide a complete conventional karyotype.

Common pitfall: A normal targeted interphase result does not exclude rearrangements outside the probe design. A metaphase localization result also does not automatically establish clone frequency.

European guidelines for constitutional cytogenomic analysis

16.What does a break-apart FISH pattern establish?

Break-apart probes label sequences on opposite sides of a target region. Closely associated signals are expected when those regions remain together; sufficient separation under validated scoring criteria supports a rearrangement involving that region. The design is useful when several partner genes are possible because it does not require a specific partner probe. However, a split signal generally identifies disruption of the targeted region rather than naming the partner or proving an expressed fusion.

Apply it

A validated break-apart assay shows a reproducible split pattern above its cutoff. Report the supported rearrangement finding, then use a partner-specific or molecular method if identifying the fusion partner is necessary for the clinical question.

Common pitfall: Naming a fusion partner from a break-apart result exceeds the probe's information. Minor separation or unusual signal loss also requires assay-specific interpretation and controls.

European guidelines for constitutional cytogenomic analysis

17.How is a canonical dual-fusion FISH pattern interpreted?

A dual-fusion assay uses differently labeled probes for two target regions and detects their juxtaposition on derivative chromosomes. In an idealized balanced reciprocal rearrangement detected by an appropriate design, the classic pattern is one separate signal of each color plus two fusion signals. The exact expected pattern is probe-specific. Signal overlap alone is insufficient without validated scoring, and deletions, complex rearrangements or variant breakpoints can alter the canonical pattern.

Apply it

An IGH/MYC dual-fusion assay yields one separate red signal, one separate green signal and two fusion signals in an abnormal population. Compare this with the assay's validated expected pattern and controls before documenting the rearrangement.

Common pitfall: Applying one dual-fusion pattern to every probe design can misclassify real variants. Chance overlap in a single nucleus is not equivalent to a validated positive result.

IGH/MYC IQFISH Dual Fusion Probe: Instructions for Use

18.How do control probes distinguish amplification from chromosome gain?

A locus-specific signal count reflects copies of the target region, but additional copies may arise through whole-chromosome gain, regional duplication or amplification. A suitable internal control helps distinguish these possibilities by providing a comparator within the same nucleus. Evaluate both absolute patterns and the assay's validated interpretive method. A centromeric control is informative but not infallible because its own region can be altered, and sectioning or nuclear overlap can distort either count.

Apply it

Tumor nuclei show many clustered target signals while the control usually remains at two copies. This favors disproportionate target gain over simple whole-chromosome polysomy, provided morphology, assay validation and control performance support interpretable nuclei.

Common pitfall: Three target signals alone do not establish amplification. Assuming every control region remains biologically unchanged can also conceal complex chromosome or regional copy-number alterations.

European guidelines for constitutional cytogenomic analysis

19.Why must DNA be denatured before FISH hybridization?

FISH depends on complementary nucleic acid strands pairing with accessible target sequences. Denaturation separates double-stranded DNA so labeled probe can hybridize to its complement. Insufficient denaturation can reduce target access and weaken signals; excessive processing can damage morphology or nucleic acid integrity. Hybridization then requires appropriate conditions for sequence-specific binding. Denaturation creates access, whereas the subsequent wash removes inadequately bound probe; these steps solve different analytical problems.

Apply it

Both target and control signals are weak across a preparation with otherwise recognizable nuclei. Review denaturation, pretreatment and hybridization conditions before interpreting widespread signal absence as simultaneous deletion of multiple unrelated genomic regions.

Common pitfall: A missing signal is not automatically a deletion. Failed target access or hybridization can produce the same visual absence without any biological copy-number loss.

IGH/MYC IQFISH Dual Fusion Probe: Instructions for Use

20.How does posthybridization wash stringency affect FISH specificity?

Posthybridization washing removes unbound and weakly bound probe while preserving sufficiently stable probe–target hybrids. Stringency reflects factors including temperature and ionic conditions. Excessively stringent washing can remove specific signal; insufficient stringency can leave background and nonspecific binding. Interpret diffuse fluorescence, weak discrete signals and control performance together. Changing wash conditions without controlling other processing steps can obscure whether a problem originates in hybridization, washing or the specimen itself.

Apply it

A batch develops high diffuse fluorescence after a wash solution preparation error. Recheck composition and temperature against the assay instructions, then evaluate a controlled repeat before altering positivity thresholds to accommodate the background.

Common pitfall: Lowering scoring standards cannot correct poor analytical specificity. Stronger washing may reduce background but can also eliminate true signals when conditions exceed the validated range.

IGH/MYC IQFISH Dual Fusion Probe: Instructions for Use

21.Why can FFPE sections show fewer FISH signals than intact nuclei?

A tissue section may contain only part of a nucleus, physically excluding one or more target regions from the examined plane. This nuclear truncation can produce apparent signal loss without a true genomic deletion. Fixation and pretreatment introduce additional specimen-specific effects. Interpretation therefore requires validated section-based criteria, suitable controls and selection of appropriate nuclei. Signal loss must be distinguished from a reproducible abnormal population whose pattern exceeds expected sectioning-related background.

Apply it

Scattered nuclei in an FFPE section show one signal instead of two, including nuclei in non-neoplastic tissue. Assess truncation background and the validated cutoff before interpreting the tumor as having a clonal deletion.

Common pitfall: Scoring every one-signal nucleus as deleted converts a predictable sectioning artifact into disease. Cutoffs established on intact suspension nuclei may not transfer to tissue sections.

ACMG Technical Standards for Clinical Genetics Laboratories: Section E, Clinical Cytogenetics

22.How does normal FISH background become an interpretive cutoff?

Negative specimens can contain abnormal-appearing signal patterns from truncation, coincidental overlap, signal separation or imperfect hybridization. Validation measures the frequency of each relevant pattern in appropriate negative specimens scored with the intended preparation, denominator and criteria. An appropriate statistical upper bound on this normal background can define the normal cutoff. The selected statistical method must suit the data and intended use; no method or percentage is universal. Positive controls separately demonstrate detection of the intended abnormality. Borderline values require attention to scoring precision and specimen quality because a small counting difference can move a result across the threshold.

Apply it

Hypothetical example: validation of a particular FFPE assay, using 200 suitable nuclei per specimen, establishes an upper background cutoff of 5.0% for its defined abnormal pattern and a decision rule requiring more than 5.0%. A patient result of 8/200 is 4.0% and does not exceed that cutoff; 24/200 is 12.0% and exceeds it if controls and signal quality are acceptable. A result of 11/200 is 5.5%, only one nucleus above 10/200 at the cutoff. Assess independent-reader agreement, eligibility of the scored nuclei, signal quality and related histologic or laboratory findings. Additional scoring or repeat testing should follow a predefined approach rather than continue until the preferred classification appears. These numbers illustrate interpretation and are not recommended universal thresholds.

Common pitfall: A cutoff is an upper estimate of normal background, not the mean background rate or proof that every pattern above it is biological. Transferring a blood cutoff to FFPE sections ignores preparation effects, and treating 5.5% as decisively different from 5.0% ignores finite sampling and reader precision.

ACMG-Section-E9-Techincal-Standards-and-Guidelines-FISH.pdf

23.Why can plasma cell enrichment improve FISH sensitivity?

A marrow contains many non-plasma cells, so an abnormal plasma cell population may be diluted in an unselected nuclear suspension. Enrichment or validated identification of plasma cells directs analysis toward the clinically relevant population and can increase detection of its abnormalities. The resulting abnormal percentage describes the analyzed population, not necessarily all marrow cells. Enrichment quality and target-cell representation remain important because selection does not guarantee that every retained cell is neoplastic.

Apply it

A marrow has a small plasma cell fraction and a negative unselected FISH result. Consider a validated plasma cell enrichment or identification approach before concluding that the clinically relevant plasma cell population lacks the targeted abnormality.

Common pitfall: Comparing enriched and unenriched percentages as if they used the same denominator can create a false impression of disease progression or an analytical contradiction.

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms

24.Which abnormalities can copy-number microarrays miss?

Copy-number microarrays measure relative genomic dosage across interrogated regions and can detect gains or losses below conventional chromosome resolution. A balanced translocation or inversion may produce no dosage change and therefore escape detection. Sensitivity also depends on probe coverage, mosaic fraction, analytical thresholds and platform design. Whole-genome ploidy changes are platform-dependent; SNP information can reveal patterns that dosage-only analysis may not. A normal array is therefore not a universal exclusion of chromosome abnormalities.

Apply it

A patient has a normal copy-number array, but family history suggests a balanced reciprocal translocation. Conventional chromosome analysis can address chromosome structure and arrangement that a dosage-only result does not adequately evaluate.

Common pitfall: Higher genomic resolution does not mean broader detection of every abnormality class. Balanced structure and low-level mosaicism can remain unresolved despite a technically satisfactory array.

European guidelines for constitutional cytogenomic analysis

25.How do SNP arrays distinguish homozygosity from deletion?

SNP arrays combine dosage measurements with allele-pattern information. A region of homozygosity can retain two copies while lacking heterozygous SNP calls; a deletion instead shows reduced dosage alongside its allele pattern. Extensive homozygosity on one chromosome can raise concern for uniparental disomy, while multiple distributed regions can suggest shared parental ancestry. These are interpretive clues, not automatic proof of parent of origin, and may require parental or other targeted studies.

Apply it

An array shows a long homozygous segment on one chromosome with normal copy number. Evaluate possible uniparental inheritance and its clinical relevance rather than reporting the segment as a deletion solely because heterozygous calls are absent.

Common pitfall: Absence of heterozygosity and loss of DNA are different findings. Copy-neutral homozygosity alone also cannot establish parental origin or exclude every form of uniparental disomy.

European guidelines for constitutional cytogenomic analysis

26.How is a constitutional copy-number variant classified?

Constitutional CNV classification integrates dosage sensitivity, gene and region content, population evidence, published observations, segregation and inheritance under a structured evidence framework. The five categories are pathogenic, likely pathogenic, uncertain significance, likely benign and benign. Size alone does not establish significance, and inheritance from an apparently unaffected parent does not automatically establish benignity. Keep classification of the variant's evidence separate from explaining how well it accounts for an individual patient's findings.

Apply it

A small deletion includes a well-established dosage-sensitive region, while a much larger gain contains limited relevant evidence. Evaluate each through its actual evidence rather than ranking pathogenicity by size or gene count alone.

Common pitfall: An uncertain classification is not a weakly positive diagnosis. Conversely, an unaffected carrier does not erase established dosage evidence when penetrance or expression can vary.

ACMG Technical Standards for Clinical Genetics Laboratories: Section E, Clinical Cytogenetics

Chromosome Analysis and Imaging45–50%

27.How are chromosomes counted when sister chromatids are visible?

A replicated metaphase chromosome consists of two sister chromatids joined at a centromeric region, but it is counted as one chromosome before sister separation. Thus, an ordinary diploid metaphase has 46 chromosomes despite containing 92 chromatids. Count discrete chromosome units and verify ambiguous overlaps or separations against morphology. Confusing chromatids with chromosomes creates a false polyploid interpretation, while broken or separated material can create additional counting errors.

Apply it

A clear metaphase contains 46 replicated structures, each with two visible sister chromatids. Record 46 chromosomes, then assess their identity and structure; the visible pairing does not make the cell a 92-chromosome tetraploid cell.

Common pitfall: DNA replication doubles DNA content without doubling the metaphase chromosome count. Counting every chromatid separately confuses cell-cycle state with a numerical chromosome abnormality.

NHGRI: Chromosome Abnormalities Fact Sheet

28.How are chromosome arms and band positions read?

The centromere divides a chromosome into the short p arm and long q arm. Cytogenetic regions and bands are numbered outward from the centromere toward the telomere, with additional subdivisions at higher resolution. A location such as 7q31 identifies chromosome 7, its long arm, region 3 and band 1. These are positional designations, not base-pair coordinates, and apparent precision must remain consistent with the band resolution actually achieved.

Apply it

A colleague places q21 distal to q31 on a chromosome diagram. Correct the order: increasing band designations move outward from the centromere, so q31 is more distal than q21 on that arm.

Common pitfall: Band numbers do not count inward from the telomere. A band-level assignment also should not be presented as an exact sequence breakpoint without molecular evidence.

MedlinePlus Genetics: How do geneticists indicate the location of a gene?

29.Why does band resolution change structural detection?

Less condensed chromosomes display more distinguishable bands, allowing recognition of smaller structural changes than highly contracted chromosomes. Band resolution describes the detail available for analysis, not simply image magnification or stain darkness. A preparation may be suitable for detecting a large rearrangement yet insufficient for a subtle suspected deletion. Match analytical claims to achieved resolution and use complementary targeted or genomic methods when the clinical question requires information below that level.

Apply it

An indication raises concern for a small deletion, but only highly contracted metaphases are available. Improve the preparation or use an appropriate complementary assay rather than interpreting a normal low-resolution karyotype as excluding the suspected lesion.

Common pitfall: Enlarging a digital image increases display size, not biological band detail. Reporting high-resolution exclusion from contracted chromosomes overstates what the preparation can support.

European guidelines for constitutional cytogenomic analysis

30.How do ordered band landmarks resolve an incorrect homolog placement?

A karyogram arranges chromosome images in an established format so homologs can be compared for size, centromere position and ordered bands, conventionally with p arms upward. Identify several landmarks on both arms rather than matching length or one dark band. For a schematic homolog exercise, let C denote the centromere, D a dark band and L a light interval. A hypothetical reference homolog A has pter–L–broad D–L–C–narrow D–wide L–D–L–D–qter; reference homolog B has pter–D–L–D–C–wide L–broad D–L–narrow D–qter. These invented maps illustrate comparison and are not named human chromosome ideograms. The paired distal q-arm dark bands of A and broad middle q-arm band of B provide decisive landmarks even if total lengths are similar.

Apply it

Suppose software places image X beside reference A and image Y beside reference B. X instead has B's two p-arm dark bands and q-arm sequence wide L–broad D–L–narrow D. Y has A's single broad p-arm dark band and q-arm sequence narrow D–wide L–D–L–D. Swap X and Y: each then matches its homolog's landmarks in the same centromere-to-telomere order. Return to the source metaphase and trace each segmented chromosome from pter through C to qter, confirming that its bands belong to one continuous chromosome and that no overlap, omitted segment or duplicated image produced the apparent match. If the source shows a genuine unmatched segment, investigate a structural change rather than forcing placement.

Common pitfall: An attractive karyogram or similar chromosome length does not establish identity. Rotation changes display orientation but cannot correct a mismatched band sequence; the source metaphase must confirm that segmentation preserved the observed structure.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline · NHGRI: Chromosome Abnormalities Fact Sheet

31.What does 47,XX,+21 specify?

The notation 47,XX,+21 describes a cell with 47 chromosomes, an XX sex chromosome complement and an additional chromosome 21. It represents free trisomy 21 rather than identifying a translocation mechanism. Down syndrome can also result from extra chromosome 21 material carried in a rearrangement or from mosaicism. The complete chromosome finding matters because similar clinical outcomes can arise through mechanisms with different implications for parental studies and recurrence assessment.

Apply it

A child's metaphases contain three separate chromosome 21 homologs and a total of 47 chromosomes with XX. Describe the finding as 47,XX,+21 rather than assigning a Robertsonian translocation that was not observed.

Common pitfall: Down syndrome is a clinical condition, not a single interchangeable karyotype. The notation for free trisomy should not be used for extra 21 material on a derivative.

MedlinePlus Genetics: Down syndrome

32.How do monosomy and trisomy differ from structural imbalance?

Monosomy is the loss of one chromosome from the usual pair; trisomy is the presence of a third copy. These are whole-chromosome aneuploidies. A segmental deletion or duplication instead changes dosage of part of a chromosome and may leave the total chromosome count unchanged. Establish both chromosome identity and structural integrity because a count of 46 can conceal substantial imbalance, while a count of 45 may sometimes reflect a balanced Robertsonian arrangement.

Apply it

A metaphase has 46 chromosomes, but one homolog has a clear terminal deletion. Classify the finding as structural imbalance rather than rejecting it because the total count remains within the ordinary diploid number.

Common pitfall: Normal total chromosome number does not establish normal genomic dosage. Likewise, an unusual total count must be interpreted with chromosome structure before assigning whole-chromosome loss.

NHGRI: Chromosome Abnormalities Fact Sheet

33.What distinguishes polyploidy from multiple individual chromosome gains?

Polyploidy changes the number of complete chromosome sets. Triploidy has three haploid sets, ordinarily totaling 69 chromosomes, and tetraploidy has four, ordinarily totaling 92. Aneuploidy changes individual chromosome numbers without adding an entire set. Evaluate the overall representation of homologs and specimen context rather than relying on an approximate count. An isolated polyploid cell in culture may have a different interpretation from a reproducible population across appropriate independent observations.

Apply it

A well-preserved metaphase contains three representatives of essentially every chromosome and totals 69. This supports triploidy, whereas a near-diploid cell with several unrelated gains represents an aneuploid pattern rather than three complete sets.

Common pitfall: A high chromosome count alone does not prove polyploidy. Overlapping metaphases or extensive acquired aneuploidy can mimic a multiple-set count without the expected set structure.

NHGRI: Chromosome Abnormalities Fact Sheet

34.Why can a balanced reciprocal translocation still matter clinically?

A reciprocal translocation exchanges segments between nonhomologous chromosomes. When no material is visibly gained or lost, it is described as apparently balanced at the method's resolution. A carrier may be unaffected, but reproductive segregation can produce unbalanced gametes. Clinical effects can also arise from disrupted genes or undetected imbalance. Therefore, apparent cytogenetic balance describes the observed dosage relationship and does not guarantee absence of every molecular or reproductive consequence.

Apply it

An adult with recurrent pregnancy loss has an apparently balanced reciprocal translocation and no major health concerns. Explain that normal health does not eliminate the possibility of unbalanced reproductive products, and interpret relevant family studies accordingly.

Common pitfall: Calling a rearrangement balanced is not equivalent to declaring it harmless. Conventional analysis cannot exclude every breakpoint-level disruption or small associated gain or loss.

MedlinePlus Genetics: Can changes in the structure of chromosomes affect health and development?

35.How can translocation Down syndrome occur with 46 chromosomes?

Down syndrome can result when extra chromosome 21 long-arm material is attached to another chromosome, commonly through a Robertsonian rearrangement. The relevant dosage can therefore be increased without a total count of 47. A balanced carrier of a common Robertsonian translocation may have 45 chromosomes while retaining the principal long-arm content. Distinguishing the child's unbalanced finding from a parental balanced rearrangement is essential for explaining inheritance and selecting appropriate parental chromosome studies.

Apply it

A child has 46 chromosomes, including a Robertsonian 14;21 chromosome and two separate chromosome 21 homologs. Recognize three copies of 21q material and investigate parental chromosomes to clarify whether the rearrangement was inherited.

Common pitfall: Counting 46 chromosomes does not exclude Down syndrome. Conversely, a balanced Robertsonian carrier with 45 chromosomes does not necessarily have monosomy for the involved long arms.

MedlinePlus Genetics: Down syndrome

36.Which feature separates pericentric from paracentric inversions?

An inversion reverses a chromosome segment after breaks and reinsertion in the opposite orientation. A pericentric inversion includes the centromere and has breakpoints in both arms; a paracentric inversion stays within one arm and excludes the centromere. This distinction depends on breakpoint position, not inversion size. An apparently balanced inversion can still affect genes or reproduction, and clinical interpretation requires distinguishing an established variant from a potentially significant rearrangement.

Apply it

Band order is reversed between a breakpoint on 3p and another on 3q. Because the inverted segment crosses the centromere, identify the inversion as pericentric before considering its specific breakpoint and inheritance implications.

Common pitfall: A large inversion confined to one arm remains paracentric. Size and visible change in chromosome shape do not replace locating the centromere relative to both breakpoints.

MedlinePlus Genetics: Can changes in the structure of chromosomes affect health and development?

37.How do deletions and duplications change regional dosage?

A deletion removes chromosome material; a duplication adds an extra copy of a segment. Either can be terminal or interstitial and can alter dosage without changing the total number of chromosomes. Banding identifies sufficiently large structural changes, while molecular methods can refine affected intervals. Phenotypic impact depends on the genes and regulatory regions involved, dosage sensitivity and genomic context rather than simply the visible size or whether the change is a gain or loss.

Apply it

A homolog appears longer because a band sequence is repeated, while its partner has the usual pattern. Consider a duplication and use suitable confirmation or genomic characterization to define the gained interval rather than assigning whole-chromosome trisomy.

Common pitfall: A larger chromosome is not automatically a benign size variant. Conversely, apparent shortening can reflect contraction, so structural interpretation requires reproducible band landmarks and adequate resolution.

MedlinePlus Genetics: Can changes in the structure of chromosomes affect health and development?

38.How do ring chromosomes form and become unstable?

A ring chromosome forms when chromosome ends join into a circular structure, often following terminal breaks and loss of distal material. Some rings form without substantial detectable terminal loss, so ring morphology alone does not define exact dosage. Rings can behave unstably during cell division, producing variable cell populations or secondary abnormalities. Interpretation therefore combines structural identification, assessment of lost or retained material and evaluation of mosaicism rather than treating every ring as a uniform lesion.

Apply it

A ring chromosome appears in several cells, with other cells showing loss or altered ring forms. Evaluate ring identity and copy-number content while considering mitotic instability as a contributor to the observed cellular variation.

Common pitfall: Assuming every ring contains the entire original chromosome overlooks terminal loss. Assuming every ring loses the same amount overlooks the need for case-specific genomic characterization.

MedlinePlus Genetics: Can changes in the structure of chromosomes affect health and development?

39.What dosage pattern does an isochromosome create?

An isochromosome has two copies of the same chromosome arm instead of one p arm and one q arm. Replacing a normal homolog with an isochromosome generally causes relative loss of one arm and gain of the other. The mirrored arm pattern is the structural clue. Clinical interpretation depends on which chromosome and arm are involved, whether another normal homolog is present and whether the finding is constitutional, acquired or mosaic.

Apply it

One X chromosome has two long arms arranged around its centromeric region and lacks the usual short arm. Recognize an isochromosome Xq pattern, then assess the resulting Xp deficiency and Xq dosage in the full complement.

Common pitfall: Two similar arms do not mean two complete chromosomes. Describing the finding only as a duplication misses the accompanying loss of the opposite arm.

MedlinePlus Genetics: Can changes in the structure of chromosomes affect health and development?

40.Why can a dicentric chromosome be mitotically unstable?

A dicentric chromosome contains two centromeric regions. If both are functionally active and attach to opposite spindle poles, segregation can produce an anaphase bridge and chromosome breakage. Some chromosomes with two centromeric regions are more stable when one centromere is inactive or their behavior permits coordinated segregation. Distinguish the structural observation of two centromeres from assumptions about functional activity, stability or the precise mechanism that created the chromosome.

Apply it

An unusual chromosome has two centromeric regions and variable secondary structural forms across cells. Consider dicentric-associated instability, but use suitable evidence before claiming that both centromeres are active or that bridging caused every observed change.

Common pitfall: Two visible centromeric regions do not prove two active kinetochores. Conversely, apparent stability does not justify overlooking a chromosome's dicentric structure during identification.

MedlinePlus Genetics: Can changes in the structure of chromosomes affect health and development?

41.Why can mosaicism differ between tissues?

Mosaicism comprises genetically distinct cell populations derived from one fertilized egg, commonly following a postzygotic chromosome segregation error. Their distribution depends on developmental timing, lineage contribution and subsequent selection. Blood may therefore show a different proportion from skin or another tissue, and culture can alter observed representation. A normal result in one specimen does not universally exclude mosaicism elsewhere; additional tissue testing should address a specific clinical and analytical question.

Apply it

Clinical findings remain suggestive of sex chromosome mosaicism despite an unremarkable blood analysis. Consider whether a clinically relevant second tissue and an appropriately sensitive method could answer the unresolved question rather than assuming uniformity across tissues.

Common pitfall: The observed blood percentage is not a direct map of every organ. A negative sampled tissue also cannot establish that a minor lineage is absent throughout the body.

MedlinePlus Genetics: Turner syndrome

42.How are culture-associated pseudomosaicism, placental mosaicism and fetal mosaicism distinguished?

Pseudomosaicism arises in vitro and does not represent a pre-existing abnormal cell population in the sampled tissue. Recurrence in independently established cultures or independent colonies supports biological mosaicism more strongly than multiple descendants within one colony. Specimen identity remains decisive: chorionic villi sample the placenta, so reproducible CVS mosaicism can represent confined placental mosaicism. Confirming an abnormal population in villi does not establish fetal involvement. Amniotic fluid provides a different specimen for assessing fetal involvement, although neither specimen establishes the distribution across all fetal tissues.

Apply it

In cultured amniotic fluid, investigate a single abnormal colony through additional independent colonies or cultures and, when informative, targeted testing of uncultured amniocytes. In CVS, assess direct and cultured findings to characterize the sampled placental populations. If mosaicism is confirmed in villi, follow-up amniocentesis can assess fetal involvement; repeating villus cultures alone cannot answer that question.

Common pitfall: Confined placental mosaicism is a biological tissue distribution, whereas pseudomosaicism is a culture artifact. A normal amniotic-fluid follow-up supports placental confinement but cannot exclude every low-level or tissue-restricted fetal population.

ACMG Technical Standards for Clinical Genetics Laboratories: Section E, Clinical Cytogenetics

43.Which observations establish a conventional acquired cytogenetic clone?

In conventional analysis of hematological neoplasms, a clone is generally supported by the same structural abnormality or chromosome gain in at least two metaphases, or loss of the same chromosome in at least three. The higher loss threshold helps distinguish recurrent biological loss from preparation-associated chromosome loss. These criteria address cytogenetic clonality within their intended setting; they do not alone establish a disease diagnosis, constitutional origin or the significance of every isolated abnormal cell.

Apply it

Two marrow metaphases share the same additional chromosome, while two other metaphases each lack a different chromosome. The repeated gain supports a clone; the unrelated single-cell losses do not combine to meet a recurrent-loss criterion.

Common pitfall: Adding unrelated losses together does not establish a clone. Applying acquired-neoplasm thresholds directly to prenatal mosaicism ignores differences in specimen biology and interpretive standards.

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms

44.How can metaphase selection bias a neoplastic result?

Cultured metaphases represent cells that survived and divided under the chosen conditions. Selecting only the cleanest or most normal-looking spreads can further underrepresent abnormal populations, especially when malignant cells have poor morphology. Use suitable metaphases while avoiding preferential exclusion of interpretable abnormal cells. Review related findings and culture conditions because a technically normal karyotype may reflect sampling of normal proliferating cells rather than absence of the neoplastic population.

Apply it

A marrow's best-looking metaphases are normal, while less tidy but interpretable cells repeatedly show a shared rearrangement. Include appropriate abnormal cells in the analysis instead of excluding them solely because their spreading is less aesthetically pleasing.

Common pitfall: Quality selection should exclude uninterpretable cells, not systematically exclude abnormal ones. The percentage among cultured metaphases is not automatically the tumor percentage in the original specimen.

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms

45.How does cell number limit exclusion of a minor population?

Under an ideal model of independent random sampling, the probability of missing a population present at fraction p in n cells is (1−p)^n. Examining more cells reduces this probability but never makes a finite sample an absolute exclusion. For a 10% population and 20 cells, the miss probability is 0.9^20, approximately 12.2%. Actual cytogenetic sampling may depart from the model because culture selection, tissue distribution and related cells violate its assumptions.

Apply it

A learner claims that 20 normal metaphases exclude a 10% abnormal population. Calculate approximately a 12.2% chance of missing it under ideal sampling, then consider whether culture bias makes the real limitation even greater.

Common pitfall: A calculated confidence applies to stated sampling assumptions. Increasing the cell count cannot fully correct a culture system that fails to recover the target population.

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms

46.How do counted cells differ from fully analyzed cells?

Counting establishes chromosome number in a suitable metaphase, while full analysis evaluates chromosome identity and structural relationships in greater detail. Preparing a karyogram documents selected cells but does not mean every examined cell received equivalent structural review. Record the actual extent of work because numerical screening cannot support the same structural exclusions as complete analysis. The appropriate combination of counts, analyses and karyograms depends on indication and applicable laboratory standards.

Apply it

A worksheet lists 20 counted cells but only a subset with complete band-by-band analysis. Describe those activities accurately rather than stating that all 20 cells were fully assessed for subtle structural abnormalities.

Common pitfall: Treating counts, analyses and karyograms as interchangeable inflates the claimed examination. A normal chromosome number alone does not exclude a balanced translocation or segmental imbalance.

ACMG Technical Standards for Clinical Genetics Laboratories: Section E, Clinical Cytogenetics

47.How does numerical aperture determine resolving ability?

Numerical aperture is n sin θ, where n is the refractive index between specimen and objective and θ is the half-angle of the accepted light cone. Higher numerical aperture generally improves light collection and resolution at a given wavelength. Immersion oil supports high numerical aperture when used with an objective designed for it. Magnification alone cannot restore unresolved detail, and incorrect immersion conditions or poor optical alignment can prevent an objective from delivering its intended performance.

Apply it

Two objectives have the same magnification but different numerical apertures. For resolving closely spaced band detail under suitable illumination, favor the higher numerical aperture objective and ensure its required immersion medium and optical conditions are correctly used.

Common pitfall: Choosing the highest magnification without considering numerical aperture can produce empty magnification. Oil should be used according to objective design rather than applied indiscriminately.

Nikon MicroscopyU: Numerical Aperture

48.How do fluorescence filters separate excitation from emission?

The excitation filter selects wavelengths that stimulate the fluorophore. A dichroic mirror directs excitation toward the specimen while allowing appropriate emitted light to reach the viewing path. The emission filter transmits the fluorescence of interest and suppresses unwanted excitation and other wavelengths. A mismatched filter set can make a present signal appear weak or absent. Evaluate channel compatibility and optical performance before interpreting missing fluorescence as a biological deletion.

Apply it

A fluorophore is bright on a verified compatible microscope but nearly invisible after a filter cube change. Check excitation, dichroic and emission compatibility before repeating specimen processing or calling the target signal absent.

Common pitfall: A dark fluorescence channel can be an optical failure. Increasing exposure may amplify background without correcting a filter set that excludes the fluorophore's emission.

Nikon MicroscopyU: Introduction to Fluorescence Microscopy

49.How does the Philadelphia rearrangement create BCR::ABL1?

The classic Philadelphia rearrangement is a reciprocal translocation between chromosomes 9 and 22 that brings ABL1 and BCR sequences together. The resulting BCR::ABL1 fusion encodes an abnormally active tyrosine kinase that promotes uncontrolled cellular proliferation. Conventional chromosome analysis identifies the visible rearrangement, while targeted molecular cytogenetic or molecular assays assess the fusion more directly. A suspected chromosome appearance should therefore be correlated with the method's resolution and appropriate related results.

Apply it

A marrow shows a small derivative chromosome 22 and a corresponding chromosome 9 rearrangement. Recognize the classic Philadelphia pattern and correlate it with targeted BCR::ABL1 testing rather than inferring molecular identity from size alone.

Common pitfall: Any small chromosome 22 is not automatically Philadelphia-positive. Conversely, a cryptic fusion may exist without the classic visibly recognizable chromosome pattern on conventional analysis.

NHGRI Talking Glossary: Translocation

50.How is a derivative chromosome identified?

A derivative chromosome is structurally rearranged and is designated by the chromosome whose centromere it retains. Its distal material may originate from another chromosome, so overall size or the most conspicuous segment does not determine its identity. Analyze centromeric origin, band continuity and exchanged segments together. In an unbalanced rearrangement, describing the derivative is only part of interpretation; the associated gains and losses across the complete chromosome complement also matter.

Apply it

A rearranged chromosome retains the chromosome 4 centromere but carries distal chromosome 8 material. Identify it as a derivative chromosome 4, then evaluate which chromosome 4 material is missing and which chromosome 8 material is additional.

Common pitfall: Naming a derivative after its largest visible segment can reverse its identity. A correct derivative label alone does not explain the patient's complete dosage imbalance.

ACMG Technical Standards for Clinical Genetics Laboratories: Section E, Clinical Cytogenetics

51.How are normal chromosome variants separated from suspicious changes?

Some chromosome differences involve variable heterochromatin or other recognized polymorphic regions rather than clinically important imbalance. Their interpretation depends on location, characteristic appearance and evidence supporting the specific variant. A familiar-looking difference should still be distinguished from a euchromatic deletion, duplication or rearrangement. Related studies can help resolve uncertainty, but familial occurrence alone is not universal proof of benignity because some pathogenic changes show reduced penetrance or variable expression.

Apply it

One homolog has a larger heterochromatic region but otherwise matching euchromatic bands. Evaluate whether it fits a recognized variant before ordering broad conclusions about pathogenicity, while investigating any atypical band change beyond the expected polymorphic region.

Common pitfall: Calling every size difference a normal variant can miss structural imbalance. Calling every heteromorphism pathogenic can also create an unsupported explanation for clinical findings.

European guidelines for constitutional cytogenomic analysis

52.How should image enhancement preserve analytical evidence?

Image capture and enhancement should improve visibility without changing the biological evidence. Appropriate exposure, focus and contrast help display bands or fluorescence, but saturation can merge signals and aggressive processing can obscure boundaries. Retain traceability to the original cell and use representative images. Enhancement cannot restore missing optical resolution or justify manufacturing a cleaner chromosome structure. Review the source metaphase whenever automated segmentation or image processing creates an unexpected appearance.

Apply it

Automated chromosome separation appears to remove a small segment from an overlapping pair. Inspect the original image and revise segmentation using the actual boundaries rather than accepting the edited karyogram as evidence of a deletion.

Common pitfall: A polished image is not necessarily a faithful one. Unrecoverable clipping, saturation or altered boundaries can invalidate interpretation even when the final display looks clear.

Scientist in Cytogenetics – CG(ASCP) and CG(ASCPi): Examination Content Guideline

53.How should observed chromosome and FISH findings become an annotated, defensible report?

Report the specimen, indication, observed findings, standardized notation, interpretation, analytical extent and limitations. Distinguish cells counted, cells fully analyzed and karyograms prepared. Describe each method's evidence separately before integrating the findings. ISCN 2024 places the multiplication sign outside the parentheses for a single-probe interphase FISH result, as illustrated in its [published correction](https://karger.com/cgr/article/165/6/369/929293/Erratum). Standardized notation documents observations; the narrative explains their significance and boundaries.

Apply it

Worked teaching report: Bone marrow investigated for a suspected myeloid neoplasm. G-banded analysis: 20 metaphases counted and fully analyzed at approximately 400-band resolution; three representative karyograms prepared. Result: 47,XY,+8[12]/46,XY[8]. Annotation: 47 is the total chromosome number in the abnormal cells; XY describes the sex chromosome complement; +8 identifies an additional chromosome 8; [12] and [8] give the numbers of metaphases with each finding. Interphase FISH on uncultured marrow: nuc ish (D8Z2)×3[120/200]. Annotation: nuc ish identifies interphase nuclear hybridization; D8Z2 identifies the chromosome 8 centromeric target; ×3 means three signals; [120/200] means that pattern occurred in 120 of 200 scored nuclei. The remaining 80 nuclei had two signals. With acceptable controls and a result exceeding the validated cutoff, interpretation is: a trisomy 8 clone is detected, with concordant targeted FISH findings. Trisomy 8 alone does not establish a specific myeloid diagnosis; correlate with morphology and molecular findings.

Common pitfall: The FISH signal count describes copies of its target, not a genome-wide chromosome assessment. Culture can select cell populations, and neither reported percentage directly measures blast percentage. State that banding can miss submicroscopic changes and targeted FISH cannot exclude abnormalities outside its target. Marrow findings alone do not establish whether an abnormality is constitutional.

European guidelines for constitutional cytogenomic analysis · European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms · ACMG-Section-E9-Techincal-Standards-and-Guidelines-FISH.pdf

Laboratory Operations10–15%

54.How is specimen traceability maintained through multiple analytical branches?

Traceability connects the patient and order to every derivative specimen, culture, slide, image, worksheet and report. Unique identifiers and documented transfers preserve this chain when one accession branches into karyotype, FISH and array workflows. Verification must occur at relevant handling transitions, not only at receipt. A result should be traceable backward to the actual material examined and forward to its authorized report so discrepancies can be investigated without reconstructing events from memory.

Apply it

A marrow accession is divided among culture, direct FISH and DNA extraction. Ensure each derived container and record retains a verified link to the accession, and document transfers before the branches enter separate work areas.

Common pitfall: Labeling only the original tube leaves later materials vulnerable to mix-up. Matching handwriting or slide position is not a substitute for an unambiguous identification system.

CMS State Operations Manual: Appendix C, Subpart K

55.Which reagent records make performance problems investigable?

Reagent identification, lot information, preparation details, concentration where relevant, storage conditions and expiration or stability limits support safe use and retrospective investigation. Labels and records must make the reagent's identity and usability clear. Document performance problems and prevent use of unacceptable material. A reagent can fail before its stated expiration through improper storage or contamination, while an unexpired label does not excuse visible deterioration or failure of an appropriate control.

Apply it

A colcemid container has acceptable dating but an unexpected change in appearance and a questionable storage history. Remove it from use pending assessment and review affected preparations instead of relying solely on the printed expiration date.

Common pitfall: Expiration dating is not a performance guarantee. Replacing a suspect bottle without recording its lot and affected cases can prevent identification of a wider quality problem.

42 CFR Part 493: Laboratory Requirements, October 1, 2025 edition · KaryoMAX Colcemid Solution: Instructions for Use, revision B.0

56.Why must equipment conditions be independently verified?

Equipment displays and programmed settings do not by themselves prove actual operating conditions. Appropriate checks of temperature, gas conditions and other relevant parameters help detect drift that can affect cell growth or assay performance. Document results, maintenance and responses to excursions so their impact on specimens can be assessed. Equipment quality control should connect observed performance to the conditions required by the method rather than become a record of numbers without interpretive action.

Apply it

An incubator display remains normal, but an independent check shows a sustained temperature deviation and several cultures grow poorly. Investigate the excursion, assess affected specimens and verify restored performance before returning the unit to routine use.

Common pitfall: Adjusting a setpoint until the display looks acceptable does not establish actual conditions. A single normal reading after repair cannot describe the entire earlier exposure period.

42 CFR Part 493: Laboratory Requirements, October 1, 2025 edition

57.Which containment system addresses biological aerosols versus chemical vapors?

Containment must match the hazard. An appropriately selected biological safety cabinet controls biological aerosol risks under its intended operating conditions, whereas a chemical fume hood captures hazardous vapors such as those arising from volatile fixatives. A standard recirculating biological safety cabinet is not a general substitute for chemical exhaust. Assess the actual chemicals, cabinet design and work process, and combine engineering controls with suitable protective equipment and documented safe handling practices.

Apply it

A worker plans to prepare volatile methanol–acetic acid fixative inside a recirculating cabinet used for cell culture. Select appropriate chemical ventilation rather than assuming that protection against biological aerosols also controls accumulated solvent vapors.

Common pitfall: A clean work surface or visible airflow does not establish chemical protection. Cabinet names alone are insufficient without understanding exhaust design and the hazard being controlled.

OSHA: Occupational exposure to hazardous chemicals in laboratories

58.How do the Chemical Hygiene Plan and safety data sheets guide action?

The Chemical Hygiene Plan sets laboratory-specific procedures and responsibilities for hazardous chemical work, including controls, training and emergency practices. Safety data sheets supply chemical-specific hazard, handling and response information. Together they connect a particular substance to the laboratory's actual work conditions. They do not replace hazard assessment or equipment performance. Staff must know where to find this information and how to apply the relevant procedures before an exposure or spill occurs.

Apply it

Before introducing a new fixative component, review its safety data sheet and determine whether the Chemical Hygiene Plan addresses its ventilation, protective equipment, storage and spill response needs. Update procedures and training where gaps exist.

Common pitfall: Keeping safety data sheets in a binder does not show that staff can use them. Generic spill instructions may be inappropriate for the actual chemical quantity and hazard.

OSHA: Occupational exposure to hazardous chemicals in laboratories

59.How does quality assessment show that corrective action worked?

Quality assessment uses meaningful indicators to identify problems, investigate causes and verify improvement. Cytogenetic examples include culture failure, inadequate band resolution, probe failure, turnaround time and identification errors. A corrective action is incomplete until subsequent evidence shows that the targeted problem improved without creating another defect. Proficiency testing and staff competency provide complementary evidence of performance, but neither replaces routine monitoring of the laboratory's own specimens, processes and error patterns.

Apply it

After changing a banding procedure, the laboratory records fewer poorly banded slides but more repeat preparations. Review both indicators to determine whether the change improved overall performance rather than celebrating one isolated metric.

Common pitfall: Documenting that staff were reminded of a procedure does not demonstrate effectiveness. A satisfactory proficiency event also cannot exclude a persistent problem in routine specimen handling.

42 CFR Part 493: Laboratory Requirements, October 1, 2025 edition

60.When is access to a patient's cytogenetic information appropriate?

Access to protected health information should be tied to authorized work responsibilities and safeguarded against inappropriate use or disclosure. A person's employment in the laboratory does not create an unrestricted reason to view every record. Use role-appropriate access, secure handling and applicable minimum-necessary practices, recognizing that the Privacy Rule has specific exceptions, including certain treatment disclosures. Cytogenetic information can have family implications, but those implications do not independently authorize disclosure to relatives or curious colleagues.

Apply it

A technologist recognizes a patient's name and wants to examine the chromosome report despite having no role in that case. Access should be based on an authorized work need rather than personal familiarity or interest.

Common pitfall: Knowing a patient or working in the same institution does not justify access. Removing a name alone may also fail to eliminate identifying information from shared records.

HHS: Summary of the HIPAA Privacy Rule

What to focus on during revision

The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.

  • Give chromosome analysis the largest study block: practise counts, band order, structural mechanisms, clone criteria and defensible limitations.
  • Trace preparation defects backward through stimulation, arrest, swelling, fixation, spreading and banding using the observed failure pattern.
  • Interpret FISH through probe design, specimen format, controls and validated cutoffs before attaching a biological conclusion.
  • Separate array dosage findings from balanced structure, copy-neutral homozygosity and evidence-based CNV classification.
  • Use U.S. regulatory sources to reason through identification, chemical controls, quality assessment and authorized information access.
  • Use the complete official outline to identify remaining topics beyond these selective concepts, including retention, disposal, emergencies and ergonomics.

A practical preparation plan

1. Map the official scope

Read the December 5, 2025 outline and mark each topic as secure, developing or unfamiliar. Allocate study time within its published domain ranges, with the largest share devoted to Chromosome Analysis and Imaging.

2. Build a preparation decision chain

For each specimen type, connect collection requirements to target cells, culture system, stimulation, harvest and slide evaluation. Practise explaining why absent growth, low mitotic index, crowded spreads and poor bands require different investigations.

3. Practise structural interpretation

Sketch chromosome complements and rearrangements. For every example, state the count, centromeric identity, altered band order, dosage consequence and one limitation. Include Robertsonian rearrangements, inversions, rings and isochromosomes.

4. Compare molecular methods

Construct examples in which karyotype, interphase FISH, metaphase FISH, copy-number array and SNP array provide different but compatible information. Explain what each result establishes and which unresolved question needs another method.

5. Review decisions with evidence

Complete the 20 questions independently, then explain why each alternative fails. Revisit the matching concept and use flashcards to retrieve mechanisms, thresholds and boundaries. Track errors by decision type rather than treating a practice score as a passing prediction.

6. Close the quality loop

Work through identification discrepancies, reagent failures, equipment excursions and privacy scenarios. For each, identify the immediate containment step, the records needed for investigation and the evidence that would demonstrate an effective correction.

Use your sample score as a starting point

The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.

Start the free sample

Official sources and updates

Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.